- Home
- ROMA vs CATX Comparison
ROMA vs CATX Comparison
Compare ROMA & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ROMA | CATX |
|---|---|---|
| Founded | 2018 | 1983 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 148.9M | 162.8M |
| IPO Year | 2024 | N/A |
Fundamental Metrics
Financial Performance| Metric | ROMA | CATX |
|---|---|---|
| Price | $2.32 | $2.71 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $11.56 |
| AVG Volume (30 Days) | 3.3K | ★ 1.9M |
| Earning Date | 12-26-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,568,345.00 | $1,075,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 23.21 | N/A |
| 52 Week Low | $0.58 | $1.60 |
| 52 Week High | $4.66 | $5.39 |
Technical Indicators
Market Signals| Indicator | ROMA | CATX |
|---|---|---|
| Relative Strength Index (RSI) | 41.27 | 58.27 |
| Support Level | $2.23 | $2.07 |
| Resistance Level | $2.51 | $2.39 |
| Average True Range (ATR) | 0.11 | 0.18 |
| MACD | -0.02 | 0.10 |
| Stochastic Oscillator | 41.70 | 75.60 |
Price Performance
Historical ComparisonAbout ROMA Roma Green Finance Limited
Roma Green Finance Ltd is principally engaged in the provision of ESG, corporate governance and risk management as well as sustainability and climate change-related advisory services. The company works closely with its clients to help them understand, identify, manage, and overcome various business matters arising from such factors related to ESG, sustainability and climate change. Geographically, the company generates its revenue from Hong Kong and Singapore.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.